Background: Evidence is contradictory whether very low-birth-weight (VLBW, birth weight <1500 g) infants with early neutropenia (NP), especially those born to mothers with preeclampsia experience a greater incidence of nosocomial infection (NI).
Introduction
Nosocomial infection (NI) is a common morbidity in very lowbirth-weight (VLBW) infants. About 20% of VLBW (birth weight <1500 g) infants develop at least one episode of NI during their hospitalization. [1] [2] [3] It has been demonstrated that NI is associated with prolonged hospital stay and increased medical costs, 4 decreased survival 5, 6 and increased likelihood of threshold retinopathy of prematurity. 7 For these reasons, prevention of NI in VLBW infants has been an important objective in the clinical practice of neonatology for the past two decades. 8, 9 Very low-birth-weight infants are thought to be at increased risk for NI for multiple factors that include invasive line(s), prolonged parenteral nutrition, 10 prolonged endotracheal intubation, 2 treatment with postnatal steroids for the prevention chronic lung disease 11 and neutropenia (NP). 12, 13 In the hope of reducing the incidence of NI among VLBW infants several strategies have been studied including prophylactic treatment with intravenous immunoglobulin, 14 antimicrobial agents 15 and treatment of NP with recombinant human granulocyte colony-stimulating factor (rhG-CSF) 16 ,17 but without any proven success. It has been suggested that prophylactic treatment with rhG-CSF or other hematopoietic growth factors might reduce the likelihood of NI in VLBW infants, especially those with NP. 17 However, many infants exhibit NP in the first week of life 18 when VLBW infants are likely being treated with broad-spectrum antibiotics empirically. These early episodes of NP usually resolve within 24-48 h and the efficacy of rhG-CSF remains unknown. Although the association between NP and NI has been reported in infants born to hypertensive mothers by 4-to 10-fold [19] [20] [21] , the incidence of NP in VLBW infants born to normotensive mothers has not been quantified. The association between maternal hypertension and risk for NI was also challenged by Mouzinho et al. 22 in their study. Our intention was to investigate whether early NP in VLBW infants, born to mothers with or without hypertension and not treated with rhG-CSF, is a significant risk factor for NI.
Methods
Computerized medical records of the University of Florida Health Science Center at Jacksonville Neonatal Intensive Care Unit were reviewed retrospectively. All premature infants with birth weights between 350 and 1500 g with gestational age p34 weeks, who survived for more than 72 h without a culture-proven bacterial or fungal infection with onset within that time, and who were not treated with rhG-CSF were included (Figure 1 ). Gestational age was determined by prenatal ultrasound before 20 weeks gestation or on the basis of the last menstrual period. All laboratory data and medication records were computerized and could be obtained upon request to link with the computerized medical records for cross reference.
In our unit a complete blood count and blood culture was routinely performed upon admission before initiation of treatment with ampicillin and gentamicin. Subsequently, a repeat complete blood count was ordered at the discretion of the care teams. The absolute neutrophil count (ANC) was obtained by multiplying the combined percentage of mature and immature neutrophil forms by the corrected total white count. NP was defined as a corrected ANC <1500 per ml. [23] [24] [25] Other definitions of NP, including Mouzinho et al. 26 revised reference ranges, were also used in our analyses. Antibiotics were discontinued if the blood culture was negative by 48-72 h. Treatment of NP with rhG-CSF in the first week was provided at the discretion of the attending neonatologists. The highest ANC in rhG-CSF-treated infants was 1420 per ml. Umbilical lines were placed by either a resident physician or a physician extender while percutaneous central venous lines were placed by a team that included five neonatologists, one nurse practitioner and four registered nurses. The indwelling catheters were removed within 24 h after discontinuation of parenteral nutrition.
Infants with one or more signs of sepsis after 72 h of life were evaluated by culturing peripheral blood (two sets), cerebrospinal fluid obtained by lumbar puncture and urine obtained by suprapubic aspiration or sterile catheterization. If any one of these cultures was positive for a bacterial or fungal pathogen, a diagnosis of NI was made with the exception that a diagnosis of coagulase negative staphylococcal sepsis required two positive cultures. A modified Bell's classification was used to stage necrotizing enterocolitis (NEC) 27 and Papile's classification was used to grade the severity of intraventricular hemorrhage (IVH). 28 IVH grades III and IV were considered as severe IVH.
Sample size calculation
We assumed an increase in the incidence of NI from 20% in VLBW infants without NP to 40% (2 Â increase) with NP, and 27% of VLBW developed early NP, 1,2 with a two-sided a-error of 0.05 and 80% power (1-b), we needed 223 (163 non-NP and 60 NP) VLBW infants for the retrospective study.
Statistic analysis
Continuous variables were expressed as mean ± standard deviation. The Student's t-test or Mann-Whitney U-test was used for comparison of continuous variables as appropriate. Categorical variables were compared using Fisher's exact test. A univariate analysis was used to determine the association between various clinical characteristics and invasive procedures and the diagnosis of NI. A multivariate stepwise logistic regression was performed, using NI as the dependent variable, with factors significantly associated with NI under univariate analyses used as the independent variables. Multiple definitions of NP were tested to identify whether any definition of NP was independently associated with NI. A receiver operating characteristic (ROC) curve was constructed using the lowest ANC in the first 7 days of life to predict the possibility of NI with sensitivity served as the x axis and (100 specificity) as the y axis. The area under curve (AUC) of ROC curve above 0.725 is usually considered as significant. A P-value <0.05 was considered statistically significant. Odds ratios (ORs) were expressed with 95% confidence interval (CI). AUC of the ROC curve is expressed as mean ± standard error (95% CI). MedCalc s version 9.2.0.1 was used for statistic analyses. The study received approval from the Institutional Review Board of the Shands Hospital at Jacksonville. Informed consent was waived because of the retrospective nature of this study and its lack of intervention on the patient population.
Results
During the study period, from January 2002 through June 2005, 338 VLBW infants were admitted to our neonatal intensive care unit <34 weeks gestation. Of which, 51 (15.1%) infants were excluded because of death or an infection with onset before 72 h, the lack of complete blood count or treatment with rhG-CSF (Figure 1 ). The 51 excluded infants were significantly less mature (25.9±2.9 versus 27.9 ± 2.7 weeks, P<0.01) and had lower birth weights (720 ± 223 versus 1061 ± 280 g, P<0.01) compared to the 287 infants who comprised the study population. Of the 332, 113 (34.0%) VLBW infants with a complete blood count available in the first week of life experienced early NP with an ANC less than 1500 per ml.
Of the 287 infants included in this study, 77 (26.8%) developed early NP. The NP infants had a lower mean birth weight and lower median 1-min Apgar score than their non-NP counterparts (Table 1 ). All 52 (67.5%) NP infants were male compared to 95 of the 210 (42.5%) non-NP infants (P<0.01). NI was absolutely but not significantly less frequent in NP compared to non-NP infants (14.3 versus 20.0%, P ¼ 0.31; Table 2 ). The median age at the first NI among NP infants (11 days, ranges 6-81 days) did not differ from the non-NP group (17 days, ranges 6-67 days). Of interest was that early NP is significantly more common in male infants with all different definitions of NP except the most restrictive definition (ANC less than 500 per ml).
The incidence of NP was not different among infants born to mothers with hypertension (preeclampsia, eclampsia, chronic hypertension, pregnancy-induced hypertension and HELLP syndrome) compared to infants of normotensive mothers (24 of 74, or 32.4% versus 53 of 213 or 24.9%, P ¼ 0.23). Among infants born to mothers with hypertension, only 2 of the 24 (8.3%) infants with NP developed NI compared to 6 of the 50 (12%) infants without NP (P ¼ 1.00). We also did not find any significant difference in the incidence of NP using either the definition of ANC less than 500 per ml or that of ANC less than 1100 per ml. Using Mouzinho's revised reference ranges of ANC, there were 9 of 59 infants (15.3%) born to hypertensive mothers who fulfilled the diagnosis of NP compared to 23 of 228 infants (10.1%) born to normotensive mothers (P ¼ 0.25).
Of the 287 infants, 53 (18.5%) developed at least one episode of NI and they were significantly (P<0.001) less mature (25.9±2.0 versus 28.4 ± 2.6 weeks) and had lower birth weights (877 ± 270 versus 1103±266 g) than their noninfected counterparts. The median 5-min Apgar score was also significantly lower in the NI group. All 53 (100%) infected infants had indwelling central venous lines and 14 (26.4%) had severe IVH, both of which rates were significantly higher than in the noninfected infants. Infants with NI were on parenteral nutrition significantly longer than infants without NI (29.5±25.6 versus 10.6±7.5 days, P<0.01). Multivariate logistic regression showed that a lower gestational age in weeks (OR 1.32, CI: 1.11-15.6) and days of parenteral nutrition (OR 1.10, CI: 1.06-1.14) were the only two factors associated with NI (r 2 ¼ 0.40). NP, regardless of the definition, was not associated with the development of NI. Threshold retinopathy of prematurity was significantly more common in infants with NI (11 of 44, or 25%, versus 7 of 214, or 3.3%, P<0.01). About half (40 of 81) of the identified pathogens were Gram-negative bacilli and one-eighth (10 of 81) were fungal species (Table 3) .
We also analyzed the data by using different criteria of NP but again failed to find an increased risk for NI. Eight infants had ANC less than 500 per ml between 2 h and 6 days of age; none developed NI and all survived to discharge (Table 4) . Of 48, 8 infants with ANC less than 1100 per ml died in hospital but only 4 (8%) developed NI; 2 developed NI within 7 days of death. The ROC curve that used the lowest ANC within 7 days to predict the development of NI revealed the AUC was only 0.57±0.04 Table 1 Demographic data of neutropenic (ANC <1500 per ml) and nonneutropenic (ANC X1500 per ml) very low-birth-weight infants (0.51-0.63) and not significantly different (P ¼ 0.10) from the line of identity ( Figure 2 ). All 20 infants born to preeclamptic mothers developed early NP but only 1 had NI as compared to 38 out of 170 infants born to normotensive mother without early NP developed NI (P ¼ 0.08). There was no difference between two groups regarding gestational age, birth weight, Apgar scores and total days on PN, central line usage, IVH, NEC, BPD, CLD and gender (data not shown). The only difference between the two groups were less premature rupture of membrane in infants born to preeclamptic mothers (2 of 20 versus 72 of 170, P<0.01).
Discussion
Neonatal mortality has gradually fallen in the past 20 years and NI remains an issue. Unfortunately, the NI rate in these vulnerable premature infants has not changed commensurately. About 20% of VLBW infants still experience at least one episode of bacterial or fungal infection during hospitalization.
1,2 One report found a threefold higher mortality rate among infants who experienced at least one episode of NI compared to infants who remained free of infection. 3 NI has also been reported to increase the length of stay and hospital charges, [29] [30] [31] [32] [33] and has been associated with greater degrees of various morbidities. Hence, prevention of NIs in VLBW infants might reasonably be expected to improve the outcome of these vulnerable infants.
Several strategies, including the prophylactic intravenous administration of immune globulin, 14 treatment of NP with rhG-CSF 16, 17 and empirical antibiotic treatment, 16 have been studied to reduce NI rates. To our knowledge, no controlled intervention with the exception of implementation of a strict infection control protocol has been shown to be effective in reducing the rate of NI.
Neutropenia, defined as an ANC <1500 per ml, affects 6-58% of premature infants in the first week of life. 22, [34] [35] [36] It was reported that about half of the premature infants born to mother with hypertension develop NP 20, 37 and at that point are more likely to develop either early-onset sepsis 37 or NI. 20 However, reports by Mouzinho et al. 26 and Paul et al. 38 failed to confirm the association between NP and NI.
Of the 332, 113 (34.0%) in our series developed early NP, consistent with the rates of NP reported by others. We previously have demonstrated that the G-CSF level in the cord blood tends to be lower in premature infants with early NP especially when the mother is preeclamptic. 39 In a preliminary report, Kocherlakota and La Gamma found that rhG-CSF might be able to prevent NI in neutropenic infants born to preeclamptic mother within their first 4 weeks of hospitalization by increasing the ANC. 16 They suggested that prophylactic treatment with rhG-CSF might be effective in reducing the incidence of NI. To date, no controlled trial has been published to examine this hypothesis. There is also no basis to be confident that rhG-CSF treatment would be effective in the treatment of early NP in VLBW infants born to normotensive mothers. In out unit, most (74%) of the VLBW infants with early NP were born to normotensive mothers, and NP was more commonly observed in male infants. Contrary to other reports, 20, 39 our data do not show a higher incidence of NP in infants born to hypertensive mothers. We also could not demonstrate in our study population that early NP was a risk factor for NI. Only 20 infants born to preeclamptic mothers developed early NP in our series but their risk of NI was not higher than the 170 infants that born to normotensive mothers without early NP. This further supports our belief that early NP does not increase the risk of NI but the limited case number does not provide enough power for the conclusion.
Conclusion
Our study showed that early NP that developed in VLBW infants without congenital infection during the first week of life did not result in a higher likelihood of NI among infants born to either preeclamptic or normotensive mothers. This observation does not support the routine use of rhG-CSF for early onset NP to prevent NI in VLBW infants.
